132 related articles for article (PubMed ID: 19822161)
21. Effects of stimulus-response compatibility on inhibitory processes in Parkinson's disease.
Beste C; Dziobek I; Hielscher H; Willemssen R; Falkenstein M
Eur J Neurosci; 2009 Feb; 29(4):855-60. PubMed ID: 19200076
[TBL] [Abstract][Full Text] [Related]
22. The unstable bridge from stimulus processing to correct responding in Parkinson's disease.
Verleger R; Schroll H; Hamker FH
Neuropsychologia; 2013 Nov; 51(13):2512-25. PubMed ID: 24051004
[TBL] [Abstract][Full Text] [Related]
23. Event-related potential changes due to early-onset Parkinson's disease in parkin (PARK2) gene mutation carriers and non-carriers.
Uslu A; Ergen M; Demirci H; Lohmann E; Hanagasi H; Demiralp T
Clin Neurophysiol; 2020 Jul; 131(7):1444-1452. PubMed ID: 32388155
[TBL] [Abstract][Full Text] [Related]
24. The error negativity in nonmedicated and medicated patients with Parkinson's disease.
Stemmer B; Segalowitz SJ; Dywan J; Panisset M; Melmed C
Clin Neurophysiol; 2007 Jun; 118(6):1223-9. PubMed ID: 17398147
[TBL] [Abstract][Full Text] [Related]
25. Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit?
Hedrich K; Hagenah J; Djarmati A; Hiller A; Lohnau T; Lasek K; Grünewald A; Hilker R; Steinlechner S; Boston H; Kock N; Schneider-Gold C; Kress W; Siebner H; Binkofski F; Lencer R; Münchau A; Klein C
Arch Neurol; 2006 Jun; 63(6):833-8. PubMed ID: 16769864
[TBL] [Abstract][Full Text] [Related]
26. Task matters - challenging the motor system allows distinguishing unaffected Parkin mutation carriers from mutation-free controls.
Prasuhn J; Borsche M; Hicks AA; Gögele M; Egger C; Kritzinger C; Pichler I; Castelo-Rueda MP; Langlott L; Kasten M; Mascalzoni D; Klein C; Pramstaller PP; Brüggemann N
Parkinsonism Relat Disord; 2021 May; 86():101-104. PubMed ID: 33895538
[TBL] [Abstract][Full Text] [Related]
27. Event related potentials, reaction time, and cognitive performance in idiopathic Parkinson's disease.
Ebmeier KP; Potter DD; Cochrane RH; Crawford JR; Stewart L; Calder SA; Besson JA; Salzen EA
Biol Psychol; 1992 May; 33(1):73-89. PubMed ID: 1600001
[TBL] [Abstract][Full Text] [Related]
28. Transcranial sonography findings in a large family with homozygous and heterozygous PINK1 mutations.
Hagenah JM; Becker B; Brüggemann N; Djarmati A; Lohmann K; Sprenger A; Klein C; Seidel G
J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1071-4. PubMed ID: 18469032
[TBL] [Abstract][Full Text] [Related]
29. Recognition memory for unfamiliar faces in Parkinson's disease: behavioral and electrophysiologic measures.
Kida Y; Tachibana H; Takeda M; Yoshikawa H; Okita T
Parkinsonism Relat Disord; 2007 Apr; 13(3):157-64. PubMed ID: 17129744
[TBL] [Abstract][Full Text] [Related]
30. Effects of aging, Parkinson's disease, and dopaminergic medication on response selection and control.
Willemssen R; Falkenstein M; Schwarz M; Müller T; Beste C
Neurobiol Aging; 2011 Feb; 32(2):327-35. PubMed ID: 19269061
[TBL] [Abstract][Full Text] [Related]
31. Event-related potentials for response inhibition in Parkinson's disease.
Bokura H; Yamaguchi S; Kobayashi S
Neuropsychologia; 2005; 43(6):967-75. PubMed ID: 15716167
[TBL] [Abstract][Full Text] [Related]
32. The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study.
Sharp ME; Caccappolo E; Mejia-Santana H; Tang MX; Rosado L; Orbe Reilly M; Ruiz D; Louis ED; Comella C; Nance M; Bressman S; Scott WK; Tanner C; Waters C; Fahn S; Cote L; Ford B; Rezak M; Novak K; Friedman JH; Pfeiffer R; Payami H; Molho E; Factor SA; Nutt J; Serrano C; Arroyo M; Pauciulo MW; Nichols WC; Clark LN; Alcalay RN; Marder KS
Mov Disord; 2015 Feb; 30(2):278-83. PubMed ID: 25393808
[TBL] [Abstract][Full Text] [Related]
33. Absence of congruency sequence effects reveals neurocognitive inflexibility in Parkinson's disease.
Rustamov N; Rodriguez-Raecke R; Timm L; Agrawal D; Dressler D; Schrader C; Tacik P; Wegner F; Dengler R; Wittfoth M; Kopp B
Neuropsychologia; 2013 Dec; 51(14):2976-87. PubMed ID: 24212103
[TBL] [Abstract][Full Text] [Related]
34. Imaging movement-related activity in medicated Parkin-associated and sporadic Parkinson's disease.
van Eimeren T; Binkofski F; Buhmann C; Hagenah J; Strafella AP; Pramstaller PP; Siebner HR; Klein C
Parkinsonism Relat Disord; 2010 Jul; 16(6):384-7. PubMed ID: 20434937
[TBL] [Abstract][Full Text] [Related]
35. Familial Parkinsonism with digenic parkin and PINK1 mutations.
Funayama M; Li Y; Tsoi TH; Lam CW; Ohi T; Yazawa S; Uyama E; Djaldetti R; Melamed E; Yoshino H; Imamichi Y; Takashima H; Nishioka K; Sato K; Tomiyama H; Kubo S; Mizuno Y; Hattori N
Mov Disord; 2008 Jul; 23(10):1461-5. PubMed ID: 18546294
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of parkin gene mutations and variations in idiopathic Parkinson's disease.
Sinha R; Racette B; Perlmutter JS; Parsian A
Parkinsonism Relat Disord; 2005 Sep; 11(6):341-7. PubMed ID: 16019250
[TBL] [Abstract][Full Text] [Related]
37. [Molecular genetics of PINK1].
Funayama M; Hattori N
Brain Nerve; 2007 Aug; 59(8):831-8. PubMed ID: 17713119
[TBL] [Abstract][Full Text] [Related]
38. Intraindividual variability in neurocognitive speed: a comparison of Parkinson's disease and normal older adults.
de Frias CM; Dixon RA; Fisher N; Camicioli R
Neuropsychologia; 2007 Jun; 45(11):2499-507. PubMed ID: 17507058
[TBL] [Abstract][Full Text] [Related]
39. Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia.
Mellick GD; Siebert GA; Funayama M; Buchanan DD; Li Y; Imamichi Y; Yoshino H; Silburn PA; Hattori N
Parkinsonism Relat Disord; 2009 Feb; 15(2):105-9. PubMed ID: 18486522
[TBL] [Abstract][Full Text] [Related]
40. [Animal models for familial Parkinson's disease].
Takahashi R
Rinsho Shinkeigaku; 2007 Nov; 47(11):938-40. PubMed ID: 18210841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
